SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION, ASSOCIATED WITH SYSTEMIC SCLEROSIS
- Authors: Volkov AV1, Martynyuk TV2, Yudkina NN1, Danilov NM2, Glukhova SI1, Guseva NG1, Chazova IE2, Nasonova VA1
-
Affiliations:
- Research Institute of Rheumatology of the Russian Academy of Medical Sciences
- Russian Cardiological Research Center
- Issue: Vol 84, No 5 (2012)
- Pages: 24-28
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31020
- ID: 31020
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A V Volkov
Research Institute of Rheumatology of the Russian Academy of Medical Sciences
Email: sandy@yahoo.com
канд. мед. наук, рук. лаб. функциональной и ультразвуковой диагностики НИИР РАМН
T V Martynyuk
Russian Cardiological Research Centerканд. мед. наук, ст. науч. сотр. отд. системных гипертензий
N N Yudkina
Research Institute of Rheumatology of the Russian Academy of Medical Sciencesмл. науч. сотр
N M Danilov
Russian Cardiological Research Center
Email: ndanilov@yandex.ru
канд. мед. наук, ст. науч. сотр. отд. системных гипертензий
S I Glukhova
Research Institute of Rheumatology of the Russian Academy of Medical Sciences
Email: sveglukhova@yandex.ru
науч. сотр
N G Guseva
Research Institute of Rheumatology of the Russian Academy of Medical Sciencesд-р мед. наук, проф., вед. науч. сотр
I E Chazova
Russian Cardiological Research Center
Email: chazova@notmail.com
д-р мед. наук, проф., член-корр. РАМН, дир.
V A Nasonova
Research Institute of Rheumatology of the Russian Academy of Medical Sciences
References
- Lee P., Langevitz P., Alderdice C. A. et al. Mortality in systemic sclerosis (scleroderma). Quart. J. Med. 1992; Suppl. 82: 139—148.
- Hesselstrand R., Scheja A., Aakesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann. Rheum. Dis. 1998; 57: 682—686.
- Steen V. D., Medsger T. A. Jr. Changes of causes of death in systemic sclerosis, 1972—2002. Ann. Rheum. Dis. 2007; 66: 940—944.
- Koh E. T., Lee P., Gladman D. D. et al. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br. J. Rheumatol. 1996; 35: 989—993.
- Kawut S. M., Taichman D.B., ArcherChicko C.L. et al. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003. 123: 344—350.
- Stupi A. M., Steen V. D., Owens G. R. et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthr. and Rheum. 1986; 29: 515—524.
- Williams M. H., Das C., Handler C. E. et al. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart 2006; 92 (7): 926—932.
- Hoeper M. M., Markevych I., Spiekerkoetter E. et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur. Respir. J. 2005; 26: 858—863.
- Masi A. T., Medsger T. A. Jr., Altman R. D. et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthr. and Rheum. 1980; 23: 581—590.
- LeRoy E. C., Black C. M., Fleischmajer R. et al. Scleroderma: classification, subsets and pathogenesis. Br. J. Rheumatol. 1988; 15: 202—205.
- Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Galie N., Hoeper M. M., Humbert M. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 2009; 34: 1219—1263.
- Badesch D. B. Update on Pulmonary Hypertension 2008. ATS Annual Session 2008. G1—S13.
- Humber M. et al. Pulmonary Arterial Hypertesion in France: Results from a National Registry. Am. J. Respir. Crit. Care Med. 2006; 173: 1023—1030.
- Sunderketter C., Herrgott I., Bruckner C. et al. Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br. J. Dermatol. 2009; 160: 835—843.
- Shah A. A., Wigley F. M., Hummers L. K. Teleangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J. Rheumatol. 2009; 37: 98—104.
- Morgan J. M., Griffiths M., de Bois R. M., Evans T. W. Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest 1991; 99: 551—556.
- Peters-Golden M., Wise R. A., Schneider P. et al. Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine (Baltimore) 1984; 63: 221—231.
- Steen V. D., Graham G., Conte C. et al. Isolated diffusion capacity reduction in systemic sclerosis. Arthr. and Rheum. 1992; 35: 765—770.
- Matucci-Cerinic M., Steen V., Nash P., Hachulla E. The complexity of managing systemic sclerosis: screening and diagnosis. Rheumatology (Oxford) 2009; 48 (Suppl 3): iii8—iii13.